{"id":55623,"date":"2009-11-30T10:25:14","date_gmt":"2009-11-30T15:25:14","guid":{"rendered":"tag:www.hepatitis-central.com,2009:\/mt\/\/1.740"},"modified":"2009-11-30T10:27:16","modified_gmt":"2009-11-30T15:27:16","slug":"government-intervention-requested-for-poor-hcv-detection-and-treatment","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/55623","title":{"rendered":"Government Intervention Requested for Poor HCV Detection and Treatment"},"content":{"rendered":"<p>Hepatitis C identification and care trends published in the December 2009 issue of <em>Hepatology<\/em> indicate a national, public health dilemma deserving of congressional action.<\/p>\n<p>NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is &#8216;Wake-Up Call&#8217; for Washington<\/p>\n<p>WASHINGTON, Nov. 24 \/PRNewswire-USNewswire\/ &#8212; New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the National Viral Hepatitis Roundtable (NVHR) said today.<\/p>\n<p>The NVHR warns that without congressional action, millions of Americans infected with chronic hepatitis C virus &#8211; particularly African Americans &#8211; are at serious risk of developing cirrhosis, liver cancer, and liver failure and will add billions of dollars in unnecessary costs to our health care system every year.<\/p>\n<p>Continue reading the entire article:<br \/>\n<a href=\"http:\/\/www.prnewswire.com\/news-releases\/nvhr-new-data-finding-fewer-than-1-in-5-hepatitis-c-patients-receiving-antiviral-therapy-is-wake-up-call-for-washington-72130697.html\">http:\/\/www.prnewswire.com\/news-releases\/nvhr-new-data-finding-fewer-than-1-in-5-hepatitis-c-patients-receiving-antiviral-therapy-is-wake-up-call-for-washington-72130697.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hepatitis C identification and care trends published in the December 2009 issue of Hepatology indicate a national, public health dilemma deserving of congressional action. NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is &#8216;Wake-Up Call&#8217; for Washington WASHINGTON, Nov. 24 \/PRNewswire-USNewswire\/ &#8212; New peer-reviewed data finding that fewer [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-55623","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/55623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=55623"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/55623\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=55623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=55623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=55623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}